STAFF FAVORITES

Silicon Valley entrepreneur becomes a rare disease hunter and advocate for his daughter, born with NGLY1 deficiency  

How the same technology driving facial and voice recognition is helping us rapidly identify novel therapies. The first in our Q&A series.

How labs are using in vitro human cells to de-risk powerful T cell therapies during early discovery. The first in our four-part series on predictive toxicology.

Science is progressing in the development of imitation meat products, but issues over taste, texture and cost remain.

Keeping an eye on the kids. New Jersey researchers hatch a plan to raise baby horseshoe crabs and then track them in the wild.

What we need is an outbreak of education about the value of routine immunizations

A genetic condition that causes victims to crave blood and resemble vampires has been the stuff of myths for centuries. Here’s what science tells us it really is.

A novel collaboration forged by the California Institute of Regeneration Medicine is helping stem cell scientists translate their therapies from the bench to the clinic 

The chances of finding a cure for this rare genetic disorder are looking better and better

In 1918 an epidemic dubbed the Spanish flu killed at least 50 million people. What have we learned since then?